A new study argues that companies relying on structural strategies alone — reorganisations, new processes, dedicated innovation units — block their own innovation efforts by neglecting the emotional dimension of corporate change.

The finding, reported by Phys.org, cuts against a persistent habit in R&D management: treating innovation as an architecture problem. Add a labs division, fund an incubator, rewrite the stage-gate. The study's authors contend these moves fail, or actively backfire, when the emotions of the people expected to innovate go unmanaged.

For R&D managers, the claim lands directly on portfolio and workflow decisions. If structure alone cannot deliver innovation, then budget reallocations and org-chart redesigns need an accompanying layer of emotional strategy — how researchers and managers experience uncertainty, risk and change.

What does the study actually claim?

The core assertion is a negative one: structural strategies that neglect emotions block innovation. The mechanism, as the study frames it, runs through people. Innovation demands that employees tolerate ambiguity, absorb setbacks and keep working through failed experiments. Structural interventions do not build that tolerance. In many cases, imposed reorganisations and process overhauls erode it.

The Phys.org report frames this as "growing pains": the discomfort that accompanies organisational change. Companies that acknowledge and work with that discomfort, rather than designing around it, stand a better chance of converting structural investment into actual innovation output.

This is not an argument against structure. It is an argument about sequencing and completeness. A new innovation unit staffed by people who feel threatened by the change it represents will likely underperform. A process redesign that ignores frustration among the researchers it touches will meet quiet resistance.

How should R&D managers read it?

Three practical implications follow from the study's framing:

• Audit the emotional cost of structural change. Before approving a reorganisation or new innovation pipeline, ask what the affected teams will feel about it — and whether that feeling has been addressed explicitly.

• Treat emotion as a variable, not noise. The study positions emotions as a decisive factor in whether structural innovation strategies succeed or stall. That puts them in the same category as budget and headcount for planning purposes.

• Expect structural-only strategies to fail. The study's central verdict is that they block innovation. Managers evaluating past failed initiatives may find the explanation here rather than in tooling or talent.

A note of analytical caution: the Phys.org summary available does not detail the study's sample size, methodology, sector coverage or funding source. Managers applying the finding should treat it as a directional research signal rather than a measured effect size, and seek the underlying publication for the study design.

Why the finding matters now

Corporate innovation spending has grown for years, while internal metrics on transformation success remain weak across industries. A recurring explanation in management research is that execution fails at the human layer, not the strategic one. This study sharpens that explanation into a specific warning: structural strategies that treat emotion as peripheral do not merely underperform — they obstruct.

For portfolio owners, that reframes a familiar risk. The question is no longer only whether the innovation structure is right, but whether the organisation's emotional readiness has been built with the same rigour as its org chart. The study suggests the two must move together, and that future corporate innovation programmes will be judged on how well they integrate both.